Who Should Pause, Proceed with Caution, or Optimize Monitoring Women with active contraceptive needs, uncontrolled thyroid disease, severe eating disorders, or personal/family history of medullary thyroid carcinoma should discuss GLP-1 therapy carefully with a qualified provider before starting
CrossRef Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases Lianna W
When it does this, it helps raise your metabolism
The critical insight is that fat loss is often still occurring during a plateau
Slower titration also allows assessment of nausea, appetite suppression, and gastrointestinal tolerance
Another study showed that acute administration of exenatide was associated with increased hepatic glucose uptake during an oral glucose tolerance test (OGTT) and a reduction in endogenous glucose production, reinforcing the hypothesis of a direct action of GLP-1 on the liver [12]